Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements longevity clinical trial healthy aging healthspan
Approach: Macro science. Palette: B, warm. Extreme macro photograph of raw berberine: a small heap of vivid yellow-orange crystalline powder with needle-like crystal clusters, shot at a low 30-degree angle with a shallow depth of field. Beside it, a dry sliver of Berberis root bark shows its bright yellow inner wood and fibrous grain. The surface is a smooth dark walnut board. Low golden-hour side light from the left makes the crystals glint like amber glass and throws long warm copper shadows across the wood. One tiny electric green highlight reflects off a glass spatula edge in the soft background blur. The mood is quiet and investigative, with rich saturated honey and burnt-orange tones and no blue cast. Photorealistic, microscopy-like texture, no text or labels.
Metabolism

Berberine vs. Metformin: Uji Pilot Nglacak Penurunan HbA1c saka 9,5% dadi 7,5%

Helix Ward · · 4 min read
#supplements #ampk #berberine #metformin #type 2 diabetes #hba1c #insulin resistance

Berberine vs. Metformin: Uji Pilot Nglacak Penurunan HbA1c saka 9,5% dadi 7,5%

Excerpt: Salah siji uji pilot cilik taun 2008 mbandhingaké berberine karo metformin ing pasien diabetes tipe 2 sing lagi diagnosa anyar. Hasilé nuduhaké penurunan HbA1c saka 9,5 % dadi 7,5 % sajrone telung wulan. Uji kapindho sing nglibataké 48 wong sing wis nampa perawatan nampilaké HbA1c mudhun saka 8,1 % dadi 7,3 % lan HOMA‑IR turun 44,7 %. Nanging loro studi iki cilik, mung kalebu wong diabetes, lan kira‑kira sapérangan peserta ngalami gangguan pencernaan. Ing ngisor iki apa data kasebut nuduhaké, apa sing ora dituduhaké, lan apa sing kudu dingerteni sadurungé mikir nggunakake berberine.

Sampeyan mesthi wis weruh geguyon ana ing internet: suplemen mirah sing dikandhakaké bisa nandingaké obat diabetes kelas pertama. Salah siji uji pilot taun 2008 ing jurnal Metabolism dadi latar belakang geguyon iki, lan angka‑angka sing diparingake pantes dipikirake kanthi teliti, kalebu bagéyan sing asring diilangi déning hype.

Hasil utama: ing wong sing anyar didiagnosa diabetes tipe 2, efek ngendhog gula berberine padha karo metformin, lan HbA1c ing kelompok berberine mudhun saka 9,5 % dadi 7,5 % ing telung wulan. Iki pancen ngetokké angka sing nggumunaké. Nanging, iki mung uji cilik sing mung kalebu wong diabetes, dudu percobaan ing bio‑hacker sehat.

Source: Yin J, Xing H, Ye J. "Efficacy of berberine in patients with type 2 diabetes mellitus." Metabolism. 2008 May;57(5):712‑7. PubMed record | DOI

Apa sing ditindakake studi iki

Artikel kasebut nyritakaké loro uji pilot sing sabené mung telung wulan.

  • Studi A: 36 wong diwasa sing anyar diagnosa diabetes tipe 2 dipérang acak dadi loro klompok – siji nampa berberine, siji nampa metformin. Saben klompok diwènèhi 0,5 g telung kaping sewengi.
  • Studi B: 48 wong diwasa sing kontrolé gula ora cukup nampa berberine tambahan saka perawatan sing wis ana, uga kanggo telung wulan.

Studi A iku perbandingan langsung berberine lan metformin. Studi B ora nduwèni grup kontrol ing abstrak; tujuwané kanggo ndelok apa berberine bisa nambah efek perawatan sing wis dipigunakaké.

Asil Studi A: berberine vs. metformin

Penulis nerangaké yèn efek hipoglikemik berberine padha karo metformin. Ing grup berberine, perubahan sing dilaporaké kaya ngéné:

Penanda Sadurunge Sawise Signifikansi
HbA1c 9,5 % ± 0,5 % 7,5 % ± 0,4 % P < .01
Glukosa puasa 10,6 ± 0,9 mmol/L 6,9 ± 0,5 mmol/L P < .01
Glukosa pos‑prandial 19,8 ± 1,7 mmol/L 11,1 ± 0,9 mmol/L P < .01
Trigliserida plasma 1,13 ± 0,13 mmol/L 0,89 ± 0,03 mmol/L P < .05

Abstrak ora nerangaké angka‑angka grup metformin, dadi tembung “padha” adhedhasar rangkuman penulis.

Asil Studi B: berberine minangka tambahan

Ing 48 pasien sing gula kontrolé ora cukup, berberine ngurangi glukosa puasa lan pos‑prandial saka minggu kapisan nganti pungkasan trial. Temuan liya:

  • HbA1c: 8,1 % ± 0,2 % → 7,3 % ± 0,3 % (P < .001)
  • Insulin plasma puasa: mudhun 28,1 % (P < .001)
  • HOMA‑IR (indikator resistansi insulin): mudhun 44,7 % (P < .001)
  • Kolesterol total lan LDL: loro‑loro mudhun sacara signifikan (angka spesifik ora diwènèhi ing abstrak)

Penurunan insulin lan HOMA‑IR iku bagéyan sing penting kanggo pamaca sing peduli kesehatan metabolik, amarga nuduhaké peningkatan sensitivitas insulin, ora mung penurunan gula. Amarga pasien tetep njupuk obat sing wis ana, percobaan iki ora bisa misahaké pengaruh berberine dewe.

Kepiye berberine bisa kerja? (Sudut pandang AMPK)

Abstrak nyebutaké yèn berberine wis kabukten ngrégulasi metabolisme glukosa lan lipid ing in vitro lan in vivo. Mekanisme sing asring diparingaké ing literatur yaiku berberine ngaktifaké AMPK, sensor energi sel sing nuntun sel supaya njupuk glukosa lan ngobong bahan bakar, tinimbang nyimpen lemak lan nggawe glukosa ing ati. Metformin uga kerep dihubungaké karo jalur AMPK, mulané perbandingan loro obat iki dadi menarik.

Nganggep iki minangka latar belakang, dudu asil saka studi iki. Studi iki mung ngukur asil klinis, ora aktivitas AMPK.

Cetakan cilik: watesan

Sadurunge ngowahi suplemen sampeyan, mangertèné watesan iki dhisik:

  • Uji pilot cilik. 36 lan 48 peserta mung cukup kanggo ngusulake hipotesis, ora kanggo negesaké temuan.
  • Mung wong diabetes. Studi A kalebu pasien anyar diagnosa, lan Studi B kalebu sing kontrolé ora cukup. Ora ana bukti apa efeké ing wong sehat utawa sing mung nduwèni gangguan metabolik ringan.
  • Desain tambahan. Studi B ora nduwèni grup kontrol tanpa berberine, mula ora bisa mbuktikaké yèn perubahan amarga berberine dewe.
  • Durasi cekak. Telung wulan ora cukup kanggo ngerteni keamanan jangka panjang utawa ketahanan efek.
  • Efek samping gastrointestinal umum. 20 pasien (34,5 %) ngalami gangguan pencernaan sing sementara. Angka iki ora cetha prabawané amarga ora dijlentrehaké jumlah total peserta sing dipertimbangkan.
  • Sinyal keamanan winates. Penulis ora nemokaké kerusakan fungsi hati utawa ginjal, nanging iki mung cek sing winates.

Sampeyan uga bisa nemokaké istilah "nature's Ozempic" kanggo berberine ing internet. Iku hype semata‑mata; studi iki ora mriksa penurunan bobot badan utawa perbandingan karo obat GLP‑1.

Apa tegese kanggo sampeyan: ringkesan praktis

  • Dosis ing studi: 0,5 g telung kaping sewengi. Artikel nyebutake iki ing lengan metformin (Studi A) lan uga kanggo berberine. Ora ana cathetan wektu mangan, nanging umume dijupuk bareng panganan kanggo ngurangi gangguan pencernaan.
  • Sapa sing relevan karo bukti iki: wong diwasa sing nduwèni diabetes tipe 2 lan diawasi dokter sing ngontrol gula lan HbA1c.
  • Sapa sing kudu ati‑ati utawa ngindhari:
    • Wong sing lagi njupuk obat diabetes, amarga nambah agen ngendhog gula bisa nambah risiko hipoglikemia.
    • Wong sing njupuk obat sing interaksi karo enzim metabolik, amarga berberine bisa mengaruhi cara obat dimetabolisme.
    • Wanita hamil, nyusui, utawa sing nduwèni penyakit hati/ginjal – tetep takon dokter dhisik.
  • Efek samping sing bisa diarepake: gangguan pencernaan sing sifaté sementara. Yen sampeyan njupuk ing ngisor pangawasan medis, ajak dokter kanggo nyetel dosis.
  • Kesimpulan utama: Berberine ora dadi pengganti obat diabetes sing wis disaranake kajaba dokter mutusaké mangkono. Pilot 2008 iki ngandhut sinyal positif sing ndadékaké studi luwih gedhé lan luwih dawa dadi perlu.

Artikel iki mung kanggo tujuan informasi lan dudu saran medis.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
HW

Written by

Helix Ward

Helix Ward writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: The human outcome. Palette: C, Natural. A close, low-angle shot of a sleeping person's bare forearm and hand resting on a rumpled white cotton duvet, a matte black smart ring on the index finger, with a small electric green LED glint on the ring's inner edge. Early morning daylight comes through a sheer curtain at the left and casts soft golden-green light across the skin, showing fine arm hair and natural skin texture. In the background, out of focus, are a wooden nightstand with a glass of water and the blurred green leaves of a houseplant by the window. The face is not shown. Shot at a 35mm equivalent with shallow depth of field, focused on the ring and knuckles. The mood is calm, restorative and quietly observational, as if the night's data were about to be checked.
supplements

Magnesium L‑Threonate Ngangkat Skor Deep lan REM Oura ing 3 Minggu

BY NOVA CHEN ·

Uji klinis acak taun 2024 nyinaoni magnesium L‑threonate (Magtein) marang 80 wong diwasa sing ngalami gangguan turu. Sawisé 21 dina ngonsumsi 1 g MgT saben dina, grup MgT entuk skor deep lan REM saka cincin Oura sing luwih dhuwur tinimbang placebo, bareng karo perbaikan suasana ati, energi, lan kewaspadaan. Nanging data iki asalé saka piranti wearable konsumen, lan ora dibandhingaké karo bentuk magnesium liyané kaya glycinate utawa citrate. Artikel iki nerangaké apa sing tenan dicritakake uji coba, pira kandungan magnesium elemental ing 1 g MgT, lan watesan-watesan panaliten iki.
**Approach: Conceptual metaphor. Palette: B, Warm.** A close, slightly high three-quarter view of a single weathered hemp rope stretched horizontally across the frame, shot at a shallow depth of field. On the left the rope is thick and tightly twisted. On the right it has frayed down to a few thin strands, with a short, neat whipping of bright electric green thread binding the rope just where the fraying stops. Golden-hour sunlight enters low from the left and picks out each individual fiber in honey and copper tones. Soft amber shadows fall across a blurred, sun-warmed wooden dock in the background. The mood is quiet and cautiously hopeful, suggesting something worn down slowly but partly held in place. The image is photorealistic and has no text.
longevity

Vitamin D3 Njaga 140 Pasangan Basa Telomer Sajrone RCT 4 Taun

BY DR. SYNAPSE ·

Sebuah uji coba acak gedhé sing dikontrol placebo nemu yèn vitamin D3 sajrone papat taun ngurangi pemendekan telomer kira‑kira 140 pasangan basa. Data iki dijupuk saka studi VITAL marang wong diwasa ing AS sing ngonsumsi 2.000 IU saben dina. Pengaruhé cilik lan mung ngancik signifikansi statistik (p = 0.039), lan dawa telomer mung penanda surrogat, dudu bukti yèn urip dadi luwih dawa. Omega‑3 ing wektu sing padha ora nuduhaké pangaruh apa‑apa marang telomer. Ing ngisor iki angka‑angka sing ditemokaké, watesan‑watesané, lan carané migunakaké temuan iki kanthi wicaksana.
Approach: the human outcome. Palette: natural. Extreme close-up of a woman's eye and the delicate skin around it, shot from a slight three-quarter angle with a 100mm macro lens and a shallow depth of field. Her skin is a mature 50s complexion with fine crow's feet that are sharp and tactile, with visible pores and soft vellus hairs. Her gaze is relaxed and not at the camera, and the face is cropped so identity isn't the focus. Soft, directional window daylight rakes across the skin from the left to bring out the wrinkle texture, with gentle warm skin tones and a blurred leafy green background outdoors. A single glass of water with a faint dissolving powder swirl sits out of focus in the foreground, with a tiny electric green leaf highlight at the edge. The mood is calm, honest and quietly scientific.
peptides

2,5 g Peptida Kolagen Ngurangi Kerutan Mata 20 % Sajeroning 8 Minggu

BY NOVA CHEN ·

Kolagen iku suplemen kecantikan lan umur panjang sing paling akèh digoleki, nanging mung sithik produk sing kuduné didhukung data klinis kontrol placebo. Ing uji coba iki, 114 wanita umur 45‑65 taun ngombe 2,5 g saben dina Verisol lan volume kerutan mata turun 20 % tinimbang placebo sawisé 8 minggu. Biopsi nuduhaké peningkatan procollagen tipe I nganti 65 % lan elastin nganti 18 %, dene fibrillin mung mundhak 6 % tanpa signifikansi. Efek iki tetep ketok nganti 4 minggu sawisé pamungkas dosis. Nanging asil iki mung kanggo siji peptida bermerek lan siji populasi, ora kanggo kabeh bubuk kolagen.
A wide, editorial-style still life photographed from slightly above on a pale warm-gray stone surface, lit by soft diffused morning light from the left. At the center, a delicate chain of 16 small, glossy beads in alternating muted terracotta, sage green, and cream is arranged in a gentle S-curve, each bead slightly different in size, like a hand-strung necklace. It stands for a peptide chain in a tactile, abstract way. Beside the chain, a translucent glass petri dish holds a thin layer of pale amber liquid with a few soft ripples. Behind it, a cross-section of a ripe fig and a halved blood orange show their intricate internal textures, suggesting cellular structure and mitochondria without literal illustration. On the left side of the frame, a small ceramic mouse figurine in matte off-white sits calmly next to a sprig of dried wheat. It is a subtle nod to the mouse study and is stylized and minimal, not cartoonish. On the right, an open, softly blurred notebook with thin hand-drawn circles and curved lines, like looping pathway diagrams, lies under a brass pen. A few pages are visible but the text is illegible. Scatter a few elements for texture: a small sprig of eucalyptus, a folded linen napkin in oatmeal tone, and a single clear glass pipette resting diagonally across the lower foreground. The palette is warm neutrals with accents of sage, terracotta, and soft amber, giving a calm, modern wellness-journal look. Shallow depth of field keeps the bead chain crisp while the background gently dissolves into creamy bokeh. Generous negative space across the upper right leaves room for headline overlay. The overall mood is clean, contemporary, and intellectually curious: scientific but warm, like a premium health and science magazine cover, with fine grain, natural shadows, and no text, logos, or futuristic elements.
peptides

MOTS‑c Dijlentrehake: Peptida Mitokondria 16 Asam Amino sing Ngaktifake AMPK lan Nglindhungi Tikus saka Obesitas Akibat Pola Mangan

BY DR. SYNAPSE ·

Peptida cilik 16 asam amino sing dienkode ing DNA mitokondria, dudu ing inti sel, ngaktifake AMPK ing otot lan nglindhungi tikus saka obesitas akibat pola mangan lan resistensi insulin ing studi *Cell Metabolism* taun 2015. MOTS‑c saiki dadi jeneng sing paling akeh dibahas ing komunitas peptida lan bio‑hacking. Nanging iki mung temuan molekuler ing tikus tanpa data manusia, lan MOTS‑c dudu terapi sing wis disetujui. Artikel iki nerangake apa iku MOTS‑c, kepiye cara kerjane liwat siklus folat lan AMPK, apa sing dituduhake ing tikus, lan apa sing kudu lan ora kudu disimpulake pembaca.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文